T 0493/09 (Hepatits C/MERCK SHARP & DOHME CORP.) of 27.2.2013

European Case Law Identifier: ECLI:EP:BA:2013:T049309.20130227
Date of decision: 27 February 2013
Case number: T 0493/09
Application number: 96936938.8
IPC class: A61K 38/21
A61K 38/19
A61K 38/18
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 186 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Continuous low-dose cytokine infusion therapy
Applicant name: Merck Sharp & Dohme Corp.
Opponent name: Sandoz AG
Krauss, Jan B.
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 113(1)
European Patent Convention Art 123(2)
European Patent Convention Art 123(3)
Rules of procedure of the Boards of Appeal Art 13(1)
Keywords: Violation of the right to be heard (no)
Late submissions - admitted (no)
Main request: amendments - allowable (yes); novelty (no)
Catchwords:

-

Cited decisions:
T 0301/87
T 0853/02
T 1459/05
Citing decisions:
-

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t090493eu1.html

Date retrieved: 17 May 2021

6 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: II Conditions to be met by an Application

General Case Law